Excision BioTherapeutics September 6, 2017 veweb Press Release “HIV Cure-Focused Excision BioTherapeutics Secures $10 Million in Seed Funding” Related Posts Nature Biotechnology "The Money Men" AFT Pharmaceuticals “Maxigesic® Partnered in 69 Countries” 2nd Annual BIO European CEO & Investor Conference